John B Green's Net Worth

$2.25 Million

Estimate Recalculated Nov 8, 2024 09:38PM EST

Who is John B Green

John B Green has an estimated net worth of $2.25 Million. This is based on reported shares across multiple companies, which include Dicerna Pharmaceuticals Inc, Verastem, Inc., and GTC BIOTHERAPEUTICS INC.

SEC CIK

John B Green's CIK is 0001243847

Past Insider Trading and Trends

2020 was John B Green's most active year for acquiring shares with 7 total transactions. John B Green's most active month to acquire stocks was the month of December. 2020 was John B Green's most active year for disposing of shares, totalling 9 transactions. John B Green's most active month to dispose stocks was the month of March. 2020 saw John B Green paying a total of $361,514.14 for 202,162 shares, this is the most they've acquired in one year. In 2020 John B Green cashed out on 188,124 shares for a total of $2,016,591.60, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Dicerna Pharmaceuticals Inc

Chief Financial Officer
Updated Apr 22, 2020
Form 4
-11.07%
-25.62K
$14.20
-$448.42K
Apr 22, 2020
205.80K
Sale
ScheduledApr 20
Form 4
-7.70%
-20.47K
$11.92
-$328.96K
Apr 09, 2020
245.48K
Sale
ScheduledApr 07
Form 4
-50.80%
-47.97K
$12.12
-$877.70K
Jan 21, 2020
46.45K
Sale
ScheduledJan 17
Form 4
108.10K
Jan 10, 2020
108.10K
Grant
Jan 08
Form 4
$5.45
$43.60K
Dec 11, 2019
238.20K
Options
Dec 11
Form 4
-4.99%
-12.50K
$15.20
-$243.75K
Nov 27, 2019
238.20K
Sale
ScheduledNov 25
Form 4
-4.75%
-12.50K
$13.25
-$195.00K
Nov 20, 2019
250.70K
Sale
ScheduledNov 18
Form 4
-24.98%
-3.56K
$20.00
-$71.24K
Nov 15, 2019
10.70K
Sale
ScheduledNov 14
Form 4
-4.48%
-12.50K
$11.73
-$156.87K
Nov 01, 2019
266.76K
Sale
ScheduledOct 31
Form 4
180.00K
Jan 04, 2019
180.00K
Grant
Jan 02
Form 4
105.00K
Jan 08, 2018
105.00K
Grant
Jan 04
Form 4
75.00K
Jan 05, 2017
75.00K
Grant
Jan 03
Form 4
265.00K
Apr 18, 2016
265.00K
Grant
Apr 14
Form 3
Jan 11, 2016
Showing 14 results

Verastem, Inc.

Chief Financial Officer
Updated Jan 04, 2016
Form 4
23.76K
Jan 04, 2016
23.76K
Grant
Jan 01
Form 4
48.24K
Nov 10, 2015
48.24K
Grant
Nov 09
Form 4
25.00%
500.00
$7.12
$3.56K
Jun 30, 2015
2.50K
Purchase
Jun 29
Form 4
33.33%
500.00
$7.39
$3.70K
Jun 29, 2015
2.00K
Purchase
Jun 26
Form 4
44.50K
Jan 12, 2015
44.50K
Grant
Jan 08
Form 4
50.00%
500.00
$8.17
$4.09K
Dec 23, 2014
1.50K
Purchase
Dec 23
Form 4
1.00K
$7.74
$7.74K
May 14, 2014
1.00K
Purchase
May 13
Form 4
60.00K
Jan 09, 2014
60.00K
Grant
Jan 07
Form 4
150.00K
Jun 05, 2013
150.00K
Grant
Jun 03
Form 3
May 15, 2013
Showing 10 results

GTC BIOTHERAPEUTICS INC

Senior VP and CFO
Updated Nov 04, 2009
Form 4
94.96%
13.72K
$1.21
$16.60K
Nov 04, 2009
34.09K
Grant
Nov 02
Form 4
-7.46%
-1.17K
$2.66
-$3.10K
Jul 02, 2009
20.37K
Tax
Jun 30
Form 4
35.00K
Apr 01, 2009
35.00K
Grant
Mar 30
Form 4
3.58%
5.40K
Feb 05, 2009
215.39K
Grant
Jan 02
Form 4
100.00K
Dec 11, 2008
287.73K
Grant
Dec 10
Form 4
25.48%
30.60K
Jul 03, 2008
187.66K
Grant
Jul 01
Form 4
66.48%
57.97K
Mar 10, 2008
174.09K
Grant
Mar 07
Form 4
1.75%
1.50K
$0.89
$1.33K
Dec 14, 2007
116.12K
Purchase
Dec 14
Form 4
22.50K
Jun 01, 2007
22.50K
Grant
May 23
Form 4
45.00K
Mar 14, 2007
45.00K
Grant
Mar 06
Form 4
1.18%
1.00K
$1.23
$1.23K
Aug 14, 2006
108.68K
Grant
Aug 10
Form 4
179.16%
76.82K
Mar 14, 2006
134.70K
Grant
Mar 10
Form 4
2.39%
1.00K
$1.39
$1.39K
May 16, 2005
57.87K
Purchase
May 16
Form 4
130.23%
45.75K
Feb 17, 2005
95.87K
Grant
Feb 15
Form 4
1.00K
Dec 13, 2004
1.00K
Grant
Dec 09
Form 4
25.00K
Feb 18, 2004
25.00K
Grant
Feb 13
Showing 16 results